Bengal Chemicals and Pharmaceuticals Limited Company Overview

Bengal Chemicals and Pharmaceuticals Limited is a well-established company in the Indian pharmaceutical industry. It was founded in 1929.

The company has a rich history of over 90 years of operation. Bengal Chemicals and Pharmaceuticals Limited has been serving the country with its wide range of products.

Bengal Chemicals and Pharmaceuticals Limited is a leading manufacturer of pharmaceuticals and chemicals in India. Its products include APIs, formulations, and specialty chemicals.

The company has a strong presence in the domestic market, with a wide distribution network across the country.

Expand your knowledge: West Bengal State Co-Operative Bank

Bengal Chemicals and Pharmaceuticals Limited experienced a significant growth in revenue, with a 56.59% increase in total revenue for the financial year ended 2023.

This growth is a testament to the company's ability to adapt and thrive in a competitive market. The company's revenue from operations also saw a substantial increase of 62.83% during the same period.

The company's total assets increased by 7.14% in 2023, indicating a moderate growth in its asset base. This is a positive sign for the company's future prospects.

Here's an interesting read: Growth Stocks Can Be Profitable Because They

The company's profit or loss saw a significant improvement, with a 40% increase in 2023. This is a major achievement for the company and a reflection of its efficient operations.

Here's a summary of the key metrics for Bengal Chemicals and Pharmaceuticals Limited:

The company's net worth also saw a moderate growth of 6.64% in 2023, indicating a stable financial position.

Bengal Chemicals and Pharmaceuticals Limited has a current team of experienced directors. Vijay Kumar Srivastava was appointed as a Nominee Director on 08 May 2023.

The company's directors include Srikumar Ghosechoudhury, who serves as a Whole-Time Director since 31 May 2023, and Sanjay Shamrao Patil, who is a Director as of 02 Jun 2023.

Here is a list of the current directors:

The ownership structure of Bengal Chemicals And Pharmaceuticals is a key aspect of its management and governance. In 2023, the company had a promoter holding of 100.00%. This means that the promoters of the company have complete control over it.

The company's financial performance is closely tied to its ownership structure. Bengal Chemicals And Pharmaceuticals had a shareholding pattern that included a significant investment from United Bank Of India, valued at ₹28.00 Cr.

Understanding the ownership structure can provide valuable insights into the company's operations and decision-making processes. The company's group structure and overseas investments are also worth exploring.

Here's a breakdown of the company's shareholding pattern:

Note that the exact amount of ₹280,000,000.00 is mentioned in the article section, but it's not clear what it refers to.

The current directors of the company are responsible for making key decisions and overseeing the organization's strategy. They are:

These directors are currently in office, with Vijay Kumar Srivastava and Srikumar Ghosechoudhury appointed on May 8th and May 31st, 2023, respectively. Sanjay Shamrao Patil joined on June 2nd, 2023.

Curious to learn more? Check out: Slaughter and May

The government is pushing forward with the strategic sale of Bengal Chemicals and Pharmaceuticals Ltd (BCPL), India's oldest pharma PSU.

The Department of Investment and Public Asset Management (DIPAM) and the Ministry of Chemicals and Fertilisers are leading the effort to clear hurdles on the path to privatisation.

BCPL was a loss-making company, but since 2016, it has started posting profits.

Buyers are interested only when a company is profitable, as explained by a government official.

The government is now looking to overturn a 2018 Calcutta High Court ruling that set aside the government's decision for the strategic sale.

The court cited the importance of public sector enterprises in providing affordable healthcare as the reason for the ruling.

BCPL was nationalised in 1980 due to financial troubles and has been a government-owned company ever since.

The company has sustained its financial recovery and is now seen as a strong candidate for a strategic sale.

The government holds a 100 percent stake in BCPL and expects significant investor interest given its improved financial position.

Bengal Chemicals and Pharmaceuticals Limited has a strong presence in the business world.

The company has a long history of innovation, dating back to 1929.

Bengal Chemicals and Pharmaceuticals Limited has a diverse product portfolio that includes pharmaceuticals, chemicals, and agrochemicals.

Their pharmaceutical division has a wide range of products, including tablets, capsules, and injectables.

The company's products are sold across various channels, including retail, wholesale, and institutional sales.

Bengal Chemicals and Pharmaceuticals Limited has a strong distribution network that enables them to reach a large customer base.

Their sales team is well-equipped to handle customer inquiries and provide support.

Broaden your view: Sales Consultant Companies

Bengal Chemicals and Pharmaceuticals Limited has a significant presence in the Indian pharmaceutical market, with a product portfolio that includes over 500 products.

The company's funding is primarily through debt, with a high debt-to-equity ratio of 1.5:1. This suggests that the company relies heavily on borrowed funds to finance its operations.

Bengal Chemicals has a strong distribution network, with a presence in over 40 countries worldwide. Its products are sold through a network of distributors and agents.

A different take: Golden 1 Credit Union

The company's manufacturing facilities are located in various parts of India, including Kolkata, Mumbai, and Bangalore. These facilities have a total production capacity of over 1,500 metric tons per annum.

Bengal Chemicals has a strong focus on research and development, with a dedicated R&D team that works on developing new products and improving existing ones.

For more insights, see: Morrison Facilities Services

Bengal Chemicals and Pharmaceuticals Limited was incorporated on March 27, 1981.

The company has a relatively small revenue of $9.67M as of March 31, 2022, and has a current employee count of 6 as of July 31, 2024.

Here's a breakdown of the company's leadership:

The company's latest Annual General Meeting (AGM) occurred on December 19, 2024, and its balance sheet was filed on March 31, 2024.

Bengal Chemicals And Pharmaceuticals has a workforce of 138 employees as of Mar 22, 2024.

The company has maintained a consistent employee count over time, with no significant fluctuations in its workforce.

The employee count is an important metric for understanding the company's size and scope, and can be a valuable indicator of its overall health and performance.

As of the latest available data, the company has 138 professional employees on its payroll.

These employees are led by a team of experienced directors, including Vijay Kumar Srivastava, Srikumar Ghosechoudhury, and Sanjay Shamrao Patil.